Freenome
South San Francisco
About Freenome
Freenome is a private biotech company that focuses on developing blood tests for early cancer detection, aiming to make screening accessible to everyone. The company aims to empower individuals in cancer prevention, detection, and treatment through innovative, non-invasive testing solutions. The company is at the forefront of non-invasive disease screening, which could transform how cancers and other diseases are proactively managed.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $500K – $1M
- Total funding: $1.5B
- Funding stage: M&A
- Last round: Corporate Round (Nov 2025)
- Website: freenome.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Oncology, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/freenome-15230 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.